Annual Cash & Cash Equivalents
$133.32 M
-$253.22 M-65.51%
31 December 2023
Summary:
AbCellera Biologics annual cash & cash equivalents is currently $133.32 million, with the most recent change of -$253.22 million (-65.51%) on 31 December 2023. During the last 3 years, it has fallen by -$460.80 million (-77.56%). ABCL annual cash & cash equivalents is now -77.56% below its all-time high of $594.12 million, reached on 31 December 2020.ABCL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$126.64 M
-$21.67 M-14.61%
30 September 2024
Summary:
AbCellera Biologics quarterly cash and cash equivalents is currently $126.64 million, with the most recent change of -$21.67 million (-14.61%) on 30 September 2024. Over the past year, it has dropped by -$45.78 million (-26.55%). ABCL quarterly cash and cash equivalents is now -84.02% below its all-time high of $792.57 million, reached on 30 June 2021.ABCL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABCL Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.5% | -26.6% |
| 3 y3 years | -77.6% | -75.5% |
| 5 y5 years | +1176.5% | - |
ABCL Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -77.6% | at low | -84.0% | +2.5% |
| 5 y | 5 years | -77.6% | +1665.1% | -84.0% | +1576.7% |
| alltime | all time | -77.6% | +1665.1% | -84.0% | +1576.7% |
AbCellera Biologics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $126.64 M(-14.6%) |
| June 2024 | - | $148.31 M(+20.0%) |
| Mar 2024 | - | $123.57 M(-7.3%) |
| Dec 2023 | $133.32 M(-65.5%) | $133.32 M(-22.7%) |
| Sept 2023 | - | $172.42 M(-4.1%) |
| June 2023 | - | $179.75 M(-6.9%) |
| Mar 2023 | - | $193.02 M(-50.1%) |
| Dec 2022 | $386.54 M | $386.54 M(+3.9%) |
| Sept 2022 | - | $371.97 M(-53.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $790.62 M(+44.9%) |
| Mar 2022 | - | $545.72 M(+14.6%) |
| Dec 2021 | $476.14 M(-19.9%) | $476.14 M(-8.0%) |
| Sept 2021 | - | $517.69 M(-34.7%) |
| June 2021 | - | $792.57 M(+15.6%) |
| Mar 2021 | - | $685.79 M(+15.4%) |
| Dec 2020 | $594.12 M(+7766.0%) | $594.12 M(+552.3%) |
| Sept 2020 | - | $91.08 M(+1105.9%) |
| Dec 2019 | $7.55 M(-27.7%) | $7.55 M |
| Dec 2018 | $10.44 M | - |
FAQ
- What is AbCellera Biologics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AbCellera Biologics?
- What is AbCellera Biologics annual cash & cash equivalents year-on-year change?
- What is AbCellera Biologics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AbCellera Biologics?
- What is AbCellera Biologics quarterly cash and cash equivalents year-on-year change?
What is AbCellera Biologics annual cash & cash equivalents?
The current annual cash & cash equivalents of ABCL is $133.32 M
What is the all time high annual cash & cash equivalents for AbCellera Biologics?
AbCellera Biologics all-time high annual cash & cash equivalents is $594.12 M
What is AbCellera Biologics annual cash & cash equivalents year-on-year change?
Over the past year, ABCL annual cash & cash equivalents has changed by -$253.22 M (-65.51%)
What is AbCellera Biologics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ABCL is $126.64 M
What is the all time high quarterly cash and cash equivalents for AbCellera Biologics?
AbCellera Biologics all-time high quarterly cash and cash equivalents is $792.57 M
What is AbCellera Biologics quarterly cash and cash equivalents year-on-year change?
Over the past year, ABCL quarterly cash and cash equivalents has changed by -$45.78 M (-26.55%)